Overall, these results confirm that the context- and time-specific involvement of P2X7 in ALS extends to the neuroinflammatory and autophagic mechanisms, thus suggesting that the lead antagonist, AXX71, deserves further investigative efforts. The gene discussed is P2RX7; the disease is amyotrophic lateral sclerosis.